Echo Therapeutics (ECTE) Reports Q1 Loss of $0.23/Share

May 20, 2016 11:24 AM EDT

Echo Therapeutics (NASDAQ: ECTE) reported Q1 EPS of ($0.23), versus ($0.72) reported last year.

For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings